期刊文献+

苯妥英钠代谢酶CYP2C9、CYP2C19基因多态性的分析 被引量:2

Analysis of CYP2C9 and CYP2C19 gene polymorphism on the metabolic enzyme of Phenytoin Sodium
下载PDF
导出
摘要 目的研究药物代谢酶基因多态性对苯妥英钠代谢的影响,并建立分析苯妥英钠代谢酶中CYP2C9、CYP2C19基因多态性的方法。方法从人全血中抽取DNA,设计引物扩增CYP2C9及CYP2C19,并运用限制性片段长度多态性(RFLP)技术的方法进行CYP2C9及CYP2C19的基因分型。结果成功设计了引物用来扩增CYP2C9及CYP2C19的基因片段,并测序验证。结论建立了简单可靠的CYP2C9及CYP2C19的RFLP基因分型方法。 Objective To study the effect of drug- metabolizing enzymes polymorphism on the metabolism of Phenytoin Sodium and to set up methods to analyse the CYP2C9 and CYP2C19 gene polymorphism. Methods The DNA were extracted from huxnan blood and PCR was used to amplify the CYP2C9 and CYP2C19 gene. Then restriction fragment length polymorphism(RFLP) was used to classify the CYP2C9 * 3 ,CYP2C19 * 2 and CYP2C19 * 3 genotypes. Results A successful design of the primers was used to contain expansion of CYP2C9 * 3, CYP2C19 * 2 and CYP2C19 * 3 and sequencing and verification were performed. Conclusion A simple and reliable PCR- RFLP method to group the CYV2C9 and CYP2C19 genotypes was established.
出处 《湘南学院学报(医学版)》 2013年第3期6-9,共4页 Journal of Xiangnan University(Medical Sciences)
基金 郴州市第一人民医院院级科研课题(N2011-009)
关键词 苯妥英钠 药物代谢酶 基因多态性 Phenytoin Sodium Drug- metabolizing enzymes Gene polymorphism
  • 相关文献

参考文献9

  • 1Yasumori T, Chen IS, LiQh, et al. Human CYP2C - mediated stereoselective phenytoin hydroxylation in Janpanese: difference in chiral preference of CYP2C9 and CYP2C19 [ J ]. Biochem Pharmacol, 1999, 57: 1297-1303.
  • 2Sakaeda T, Nakamura T, Okumura K. Pharmacogenetics of drug transporters and its impact on the pharmacotherapy[ J ]. Curt Top Med Chem, 2004, 4:1385- 1398.
  • 3Shao H, Ren XM, Lin NF, et al. Influence of CYtEC9 and CYP2C19 genetic polymorphisms on pharmacokinetics and phar- macodynamics of gliclazide in healthy Chinese Han volunteers [J]. J Clin Pharm Ther, 2010, 35:351 -360.
  • 4Akira Kubotaa, Monso C D Bainya, Bruce R. Woodina, et al. The cytochrome P450 2AA gene cluster in zebrafish (Danio re- rio): Expression of CYtEAA1 and CYP2AA2 and response to phenobarbital- type inducers[J]. Toxicology and Applied Phar- macology, 2013,272(12) : 172 - 179.
  • 5Mamiya K, Ieiri I, Imai J, et al. The effects of genetic polymor- phisms of CYP2C9 and CYF2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxulation and population pharmacokinetics [ J ]. Epilepsia, 1998, 39(12) : 1317 - 1323.
  • 6Linda Jose, Chacko Binila, SJ Chandy, et al. Acenocoumarol and phenytoin toxicity in the presence of CYP2C9 mutation[J]. Journal of Association of Physicians of India, 2008, 56 : 250 - 252.
  • 7何周康,赵昕,阳利龙,张志华.丙戊酸代谢酶中CYP2C9、UGT1A6的基因多态性分析方法的建立[J].儿科药学杂志,2008,14(6):1-4. 被引量:5
  • 8Soskin DP, Kane AJ, Stern TA. Phenytoin Toxicity Secondary to an Oxcarbazepine- Phenytoin 2C19 Interaction[J]. Psychosomat- ics, 2010, 51:532 - 535.
  • 9Kesavan R, Narayan SK, Adithan C. Influence of CYP2C9 and CYP2C19 genetic polymorphisms on phenytoin - induced neuro- logical toxicity in Indian epileptic patients[J]. Eur J Clin Phama- col, 2010, 66(7) :689 - 696.

二级参考文献20

  • 1赵嘉惠,张华屏.外周血DNA提取方法的比较及改良[J].山西医科大学学报,2006,37(1):12-13. 被引量:17
  • 2Bock KW, Forster A, Gschaidmeier H, et al. Paracetamol glucuronidation by recombinant rat and human phenol UDP- glueuronosyl transferases [ J ]. Biochem Pharmacol, 1993, 45(9) : 1809-1814.
  • 3Coffman BL, Rios GR, King CD, et al. Human UGT2B7 catalyzes morphine glucuronidation [ J ]. Drug Metab Dispos, 1997, 25(1): 1-4.
  • 4Ethell BT, Ekins S, Wang J, et al. Quantitative structure activity relationships for the glucuronidation of simple phenols by expressed human UGT1A6 and UGT1A9 [ J ]. Drug Metab Dispos, 2002, 30(6) : 734-738.
  • 5Crespi CL, Miller VP. The R144C change in the CYP2C9^*2 allele alters interaction of the cytochrome P450 with NADPH : cytochrome P450 oxidoreductase [ J ]. Pharmacogenetics, 1997, 7(3) : 203-210.
  • 6Sullivan-Klose TH, Ghanayem BI, Bell DA, et al. The role of the CYP2Cg-Leu359 allelic variant in the tolbutamide polymorphism [ J ]. Pharmacogenetics, 1996, 6 (4) : 341- 349.
  • 7Imai J, Ieiri I, Mamiya K, et al. Polymorphism of the cytochrome P450 (CYP)2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus [ J ]. Pharmacogenetics, 2000, 10 : 85-89.
  • 8Dickmann LJ, Rettie AE, Kneller MB, et al. Identification and functional characterization of a new CYP2C9 variant (CYP2C9 ^* 5 ) expressed among African Americans [ J ]. Mol Pharmacol, 2001, 60(2) : 382-387.
  • 9Kidd RS, Curry TB, Gallagher S, et al. Identification of a null aUele of CYP2C9 in an African-American exhibiting toxicity to phenytoin [ J ]. Pharmacogenetics, 2001, 11 (9) : 803 -808.
  • 10Blaisdell J, Jorge-Nebert LF, Coulter S, et al. Discovery of new potentially defective alleles of human CYP2C9 [ J ]. Pharmacogenetics, 2004, 14 (8) : 527-537.

共引文献4

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部